Literature DB >> 22956191

Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center.

Katy M Hanzelka1, Sai-Ching J Yeung, Gary Chisholm, Kelly Willis Merriman, Susan Gaeta, Imrana Malik, Terry W Rice.   

Abstract

PURPOSE: The investigation examines the impact of a standardized sepsis order set and algorithm utilizing non-invasive monitoring for early-goal directed therapy (EGDT) in an emergency center setting on the clinical outcomes of sepsis in cancer patients.
METHODS: Single-center, retrospective study comparing clinical outcomes of sepsis before and after routine usage of a standardized order set and algorithm for non-invasive elements of EGDT for sepsis in an emergency center of a comprehensive cancer center. The outcomes measures evaluated were 28-day in-hospital mortality, intensive care unit length of stay, hospital length of stay, goal mean arterial pressure and urine output within the first 6 h of treatment, time to measurement of lactic acid, and appropriateness and timeliness of initial antibiotic therapy.
RESULTS: The 28-day in-hospital mortality was significantly lower in the post-intervention group compared to the pre-intervention group (20 vs. 38%, p = 0.005). The percentages of patients who reached their goal mean arterial pressure (74 vs. 90%, p = 0.004) and goal urine output (79 vs. 96%, p = 0.002) during the first 6 h of treatment were higher the after than the before group. No significant differences were detected in the rest of the outcome measures.
CONCLUSIONS: Implementation of a standardized sepsis order set and algorithm to improve compliance with the non-invasive elements of EGDT for sepsis in cancer patients in the emergency center setting was associated with a decreased 28-day in-hospital mortality rate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22956191     DOI: 10.1007/s00520-012-1572-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  44 in total

1.  Before-after study of a standardized hospital order set for the management of septic shock.

Authors:  Scott T Micek; Nareg Roubinian; Tim Heuring; Meghan Bode; Jennifer Williams; Courtney Harrison; Theresa Murphy; Donna Prentice; Brent E Ruoff; Marin H Kollef
Journal:  Crit Care Med       Date:  2006-11       Impact factor: 7.598

2.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

3.  The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

Authors:  Mitchell M Levy; R Phillip Dellinger; Sean R Townsend; Walter T Linde-Zwirble; John C Marshall; Julian Bion; Christa Schorr; Antonio Artigas; Graham Ramsay; Richard Beale; Margaret M Parker; Herwig Gerlach; Konrad Reinhart; Eliezer Silva; Maurene Harvey; Susan Regan; Derek C Angus
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

4.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.

Authors:  H Bryant Nguyen; Stephen W Corbett; Robert Steele; Jim Banta; Robin T Clark; Sean R Hayes; Jeremy Edwards; Thomas W Cho; William A Wittlake
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

5.  Impact of the Surviving Sepsis Campaign on the recognition and management of severe sepsis in the emergency department: are we failing?

Authors:  Helen Lindsay Cronshaw; Ron Daniels; Anthony Bleetman; Emma Joynes; Mark Sheils
Journal:  Emerg Med J       Date:  2010-07-26       Impact factor: 2.740

6.  Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours.

Authors:  Anthony R Mato; Selina M Luger; Daniel F Heitjan; Mark E Mikkelsen; Erin Olson; Chaitra Ujjani; Samantha Jacobs; Andrea N Miltiades; Payal Shah; Stephen J Schuster; Martin Carroll; Ann Duskin Chauffe; Barry D Fuchs
Journal:  Cancer Biol Ther       Date:  2010-04-20       Impact factor: 4.742

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008.

Authors:  R Phillip Dellinger; Mitchell M Levy; Jean M Carlet; Julian Bion; Margaret M Parker; Roman Jaeschke; Konrad Reinhart; Derek C Angus; Christian Brun-Buisson; Richard Beale; Thierry Calandra; Jean-Francois Dhainaut; Herwig Gerlach; Maurene Harvey; John J Marini; John Marshall; Marco Ranieri; Graham Ramsay; Jonathan Sevransky; B Taylor Thompson; Sean Townsend; Jeffrey S Vender; Janice L Zimmerman; Jean-Louis Vincent
Journal:  Crit Care Med       Date:  2008-01       Impact factor: 7.598

Review 8.  Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares.

Authors:  Paul E Marik; Michael Baram; Bobbak Vahid
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

9.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

10.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

View more
  11 in total

Review 1.  Early management of sepsis with emphasis on early goal directed therapy: AME evidence series 002.

Authors:  Zhongheng Zhang; Yucai Hong; Nathan J Smischney; Han-Pin Kuo; Panagiotis Tsirigotis; Jordi Rello; Win Sen Kuan; Christian Jung; Chiara Robba; Fabio Silvio Taccone; Marc Leone; Herbert Spapen; David Grimaldi; Sven Van Poucke; Steven Q Simpson; Patrick M Honore; Stefan Hofer; Pietro Caironi
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

2.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03

Review 3.  [Cancer patients in the intensive care unit. Goals of therapy, ethics, and palliation].

Authors:  P Schellongowski
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-21       Impact factor: 0.840

Review 4.  Physiological changes after fluid bolus therapy in sepsis: a systematic review of contemporary data.

Authors:  Neil J Glassford; Glenn M Eastwood; Rinaldo Bellomo
Journal:  Crit Care       Date:  2014-12-27       Impact factor: 9.097

5.  Identification of the severe sepsis patient at triage: a prospective analysis of the Australasian Triage Scale.

Authors:  Diane J Chamberlain; Eileen Willis; Robyn Clark; Genevieve Brideson
Journal:  Emerg Med J       Date:  2014-12-11       Impact factor: 2.740

6.  Comparison of diagnostic and prognostic utility of lactate and procalcitonin for sepsis in adult cancer patients presenting to emergency department with systemic inflammatory response syndrome.

Authors:  Esra Keçe; Elif Yaka; Serkan Yılmaz; Nurettin Özgür Doğan; Cansu Alyeşil; Murat Pekdemir
Journal:  Turk J Emerg Med       Date:  2016-03-10

Review 7.  Critically ill patients with cancer: chances and limitations of intensive care medicine-a narrative review.

Authors:  Peter Schellongowski; Wolfgang R Sperr; Philipp Wohlfarth; Paul Knoebl; Werner Rabitsch; Herbert H Watzke; Thomas Staudinger
Journal:  ESMO Open       Date:  2016-09-13

8.  Consensus statement for cancer patients requiring intensive care support.

Authors:  M G Kiehl; G Beutel; B Böll; D Buchheidt; R Forkert; V Fuhrmann; P Knöbl; M Kochanek; F Kroschinsky; P La Rosée; T Liebregts; C Lück; U Olgemoeller; E Schalk; A Shimabukuro-Vornhagen; W R Sperr; T Staudinger; M von Bergwelt Baildon; P Wohlfarth; V Zeremski; P Schellongowski
Journal:  Ann Hematol       Date:  2018-04-27       Impact factor: 3.673

9.  Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review.

Authors:  Zhiyuan Tan; Zhiheng Yu; Ken Chen; Wei Liu; Rongsheng Zhao
Journal:  Front Pharmacol       Date:  2021-05-21       Impact factor: 5.810

Review 10.  Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE.

Authors:  H Bryant Nguyen; Anja Kathrin Jaehne; Namita Jayaprakash; Matthew W Semler; Sara Hegab; Angel Coz Yataco; Geneva Tatem; Dhafer Salem; Steven Moore; Kamran Boka; Jasreen Kaur Gill; Jayna Gardner-Gray; Jacqueline Pflaum; Juan Pablo Domecq; Gina Hurst; Justin B Belsky; Raymond Fowkes; Ronald B Elkin; Steven Q Simpson; Jay L Falk; Daniel J Singer; Emanuel P Rivers
Journal:  Crit Care       Date:  2016-07-01       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.